•  EN 
  • Employee login

Program Training School 3


​​​Theme: Personalized medicine and Industry​
Topic: Drug development
Learning objectives: To obtain a basic understanding of the considerations to be taken into account when preparing and executing a clinical development program for a novel medicinal product, tailored to the needs of the patient. Apart from some general framework topics like drug development concepts and use of biomarkers, area of focus will be the ‘special patient’, like the very young, the elderly, the patient with renal or hepatic impairment, and patient ethnicity.

Febr 3, 2020 ​​13.50 - 14.35​Introduction; drug development in industry
14.35 - 14.50​Break
​14.50 - 15.35Personalized medicine in pediatrics
15.35 - 16.20Personalized medicine by advanced therapy medicinal products
​16.20 - 17.05Personalized medicine in the elderly
​​Febr 5, 2020​

​12.00 - 13.00​The future of Personalized Medicine in Diabetes and Chronic Kidney Disease
​13.00 - 13.45Biomarkers in clinical drug development; the case of renal and hepatic safety markers
13.45 - 14.30 Break
14.30 - 15.15Diagnostic, prognostic and response biomarkers; concepts​
15.15 - 16.00 Personalized medicine in chronic respiratory diseases
16.00 - 16.45Ethnic factors in clinical drug development
Febr 6, 2020​13.30 - 16.00​​Visit SYNCOM​
Febr 19, 2020

​09.00 - 1​0.00​Statistical/Epidemiological perspective on datavisualisation
10.30-11.30​Visualization of research through a poster
​12.00-16.00 Practical Data Visualization​​
​Jan-June, 2020​Critical Appraisal of Literature​